Endogenous IL-33 determines the severity of Th17 cell–mediated inflammation by regulating the phenotype of antigen-presenting cells
The Journal of Immunology · 02.11.2026 · 215 (11)
DOI: 10.1093/jimmun/vkag285 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 13.11.2026. Verfasst von Jürgen Brück und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Tübingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Interleukin-33, Th17 Cells, Dendritic Cells, Inflammation. Die Arbeit nennt 69 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft (DFG), CRC.
Abstract (Originalsprache)
Cytokines of the interleukin (IL)-1 family are key mediators of cutaneous innate immunity. While the activation and function of IL-1β and IL-18 during immune responses are well characterized, the immunological properties of IL-33 are less well understood. The functions of exogenous IL-33, the therapeutic application of recombinant IL-33, and the interaction between IL-33 and its receptor ST2 are largely elucidated. In contrast, the function of endogenous IL-33 (eIL-33) is yet unknown. By investigating the immune responses in 2 different Th17-mediated experimental disease models, autoimmune encephalomyelitis and imiquimod-induced psoriasis, we found that eIL-33 dampened the Th17 immune response in vivo. Mechanistically, the absence of eIL-33 induced a stronger proinflammatory phenotype in dendritic cells (DCs), resulting in a stronger Th17 response in vivo and in vitro. Furthermore, eIL-33 influenced the expression of costimulatory molecules on antigen-presenting cells. On the molecular level, eIL-33 regulated genes like Icosl, Il12b, and Ccl17, which are associated with inflammatory autoimmune diseases. These findings demonstrate that the pleiotropic cytokine IL-33 influences, depending on its exogenous secreted or endogenous intracellular form, several signaling pathways. With these data we could unravel the mechanism of how intracellular IL-33 influences the phenotype of DCs to attenuate the differentiation of pathogenic Th17 cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, University of Tübingen, Tübingen, Germany.
- Department of Nuclear Medicine, University Medical Center Mainz, Mainz, Germany.
- Charité - University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Dermatology, Venereology and Allergology, Berlin, Germany.
- Department of Medical Statistics, University of Heidelberg, Heidelberg, Germany.
- Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
- Institute of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, Campus Benjamin Franklin.
ORCID-Profile: Kamran Ghoreschi
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
- CRC
Zitieren
APA
Brück, J., Meier, K., Holstein, J., Frauhammer, F., Carevic, M., Röcken, M., Hirahara, K., Kiuchi, M., Kokubo, K., Masuda, Y., Sasaki, A., Klose, C., Forster, P. M., Panayotova-Dimitrova, D., Schreckenberger, M., Ghoreschi, K., & Yazdi, A. S. (2026). Endogenous IL-33 determines the severity of Th17 cell–mediated inflammation by regulating the phenotype of antigen-presenting cells. The Journal of Immunology, 215(11). https://doi.org/10.1093/jimmun/vkag285
Vancouver
Brück J, Meier K, Holstein J, Frauhammer F, Carevic M, Röcken M, et al. Endogenous IL-33 determines the severity of Th17 cell–mediated inflammation by regulating the phenotype of antigen-presenting cells. The Journal of Immunology. 2026;215(11). doi:10.1093/jimmun/vkag285
BibTeX
@article{Brck2026,
author = {Brück, Jürgen and Meier, Katharina and Holstein, Julia and Frauhammer, Felix and Carevic, Melanie and Röcken, Martin and Hirahara, Kiyoshi and Kiuchi, Masahiro and Kokubo, Kota and Masuda, Yuiko and Sasaki, Atsushi and Klose, Christoph and Forster, Patrycja M and Panayotova-Dimitrova, Diana and Schreckenberger, Mathias and Ghoreschi, Kamran and Yazdi, Amir S},
title = {Endogenous IL-33 determines the severity of Th17 cell–mediated inflammation by regulating the phenotype of antigen-presenting cells},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {11},
doi = {10.1093/jimmun/vkag285}
}
EUVIMED